HRTX Heron Therapeuti
Company Analysis
Latest News
🟢 Heron Therapeutics is trading 5.2% up today amid broader market strength
Heron Therapeutics is trading at $0.52 (+5.17%) in after-hours trading, moving higher despite a lack of company-specific catalysts. • The price action appears...
🟢 Heron Therapeutics is trading 6.6% up today without a clear company catalyst
Heron Therapeutics is trading at $0.49 (up 6.6%) without a clear company catalyst, reversing several sessions of mild weakness. • No fresh company-specific...
🟢 Heron Therapeutics rises 6.1% — Biotech Sector Rallies on Blockbuster M&A Deal and Positive Trial Data
With Biotech (XBI) up 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🟢 Heron Therapeutics is trading 6.2% up today in after-hours trading with no clear catalyst
Heron Therapeutics is trading 6.2% up at $0.50 in after-hours trading despite a lack of fresh company-specific news or fundamental catalysts. • The move...
🟢 Heron Therapeutics is trading 7.1% up today in after-hours trading with no clear catalyst
Heron Therapeutics is trading 7.1% up at $0.51 in after-hours trading, extending its gains from the regular session despite a lack of fresh news or specific...
🟢 Heron Therapeutics is trading 11.2% up
Heron Therapeutics is trading at $0.49, up 11.2% from a comparison close of $0.44 during regular trading. This is a price-action follow-up, so a separate...
🟢 Heron Therapeutics is trading 5.2% up today, extending a multi-day rebound
Heron Therapeutics is trading 5.2% up at $0.46, extending a multi-day rebound from last week’s lows. • The move appears to be a continuation of recent...
🔴 Heron Therapeuti is trading 5.51% down
HRTX is trading at $0.40, down 5.51%.
Heron Therapeutics Receives Nasdaq Non-Compliance Notice Over Minimum Bid Price
Heron Therapeutics (HRTX) announced it received a notice from Nasdaq for failing to maintain the minimum $1.00 per share bid price requirement for continued...